Merck is investing more than €300 million in a new research center at its global headquarters in Darmstadt, Germany.
In the Advanced Research Center, the...
A £9.4 million collaborative research centre will accelerate improved tests, treatments and potentially cures for thousands of people living with rare respiratory diseases.
The LifeArc...
Mundipharma has acquired all assets and rights related to rezafungin globally from Cidara Therapeutics.
This provides Mundipharma with global ownership of rezafungin including ongoing development...